ASH 2023 | AutoSCT for elderly patients with multiple myeloma in their last quarter of life
Nisha Joseph, MD, Winship Cancer Institute, Emory University, Atlanta, GA, discusses autologous stem cell transplantation (autoSCT) for patients with multiple myeloma (MM) aged over 74 in their last quarter of life. Contrary to some beliefs that autoSCT may not be appropriate for this age group, Dr Joseph emphasizes the notable progression-free survival (PFS) benefits. She suggests that eligibility for autoSCT should be determined by factors such as performance status and comorbidities rather than age alone. This interview took place at the 65th ASH Annual Meeting and Exposition, held in San Diego, CA.
These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.
Disclosures
Consultancy: Janssen Oncology
Honoraria: BMS
